Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dick

Showing results (401-410 of 415) with videos related to

Pageof 42
Sort By:
JAMA Internal Medicine|September 29, 2015
Shared Decision Making for Antidepressants in Primary Care: A Cluster Randomized TrialAnnie LeBlanc, Jeph Herrin, Mark D Williams, et al.
Patient Preference and Adherence|June 8, 2022
Shared Decision-Making for Patients Hospitalized with Acute Myocardial Infarction: A Randomized TrialMegan E Branda, Marleen Kunneman, Alejandra I Meza-Contreras, et al.
The Journal of Biological Chemistry|October 5, 2011
Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analoguesJesse J Chen, Christopher A Tsu, James M Gavin, et al.
Molecular Cancer Therapeutics|December 19, 2006
Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomibMark J Williamson, Jonathan L Blank, Frank J Bruzzese, et al.
Blood|June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphomaMichael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
Cancer Cell|March 24, 2012
Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924Michael A Milhollen, Michael P Thomas, Usha Narayanan, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Molecular Cell|February 5, 2010
Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situJames E Brownell, Michael D Sintchak, James M Gavin, et al.
Journal of the American Chemical Society|October 7, 2021
Ternary Alloys Enable Efficient Production of Methoxylated Chemicals via Selective Electrocatalytic Hydrogenation of Lignin MonomersTao Peng, Taotao Zhuang, Yu Yan, et al.
Pageof 42

Showing results (401-410 of 415) with videos related to

Sort By:
Pageof 42
JAMA Internal Medicine|September 29, 2015
Shared Decision Making for Antidepressants in Primary Care: A Cluster Randomized TrialAnnie LeBlanc, Jeph Herrin, Mark D Williams, et al.
Patient Preference and Adherence|June 8, 2022
Shared Decision-Making for Patients Hospitalized with Acute Myocardial Infarction: A Randomized TrialMegan E Branda, Marleen Kunneman, Alejandra I Meza-Contreras, et al.
The Journal of Biological Chemistry|October 5, 2011
Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analoguesJesse J Chen, Christopher A Tsu, James M Gavin, et al.
Molecular Cancer Therapeutics|December 19, 2006
Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomibMark J Williamson, Jonathan L Blank, Frank J Bruzzese, et al.
Blood|June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphomaMichael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
Cancer Cell|March 24, 2012
Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924Michael A Milhollen, Michael P Thomas, Usha Narayanan, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Molecular Cell|February 5, 2010
Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situJames E Brownell, Michael D Sintchak, James M Gavin, et al.
Journal of the American Chemical Society|October 7, 2021
Ternary Alloys Enable Efficient Production of Methoxylated Chemicals via Selective Electrocatalytic Hydrogenation of Lignin MonomersTao Peng, Taotao Zhuang, Yu Yan, et al.
Pageof 42